People who have been infected with Covid-19 will have to wait 4 weeks to receive the booster dose

0
661
Una enfermera administra la vacuna contra el Covid-19 a una joven en el dispositivo puesto en marcha en la Ciutat de les Arts i les Ciències de Valencia, a 28 de julio de 2021, en Valencia, Comunidad Valenciana, (España). Este gran punto de vacunación, uno de los puestos en marcha en la Comunidad Valenciana, está dirigido a los jóvenes de entre 20 a 29 años. La Conselleria de Sanidad de Valencia tiene previsto administrar más de 105.000 vacunas para este grupo de edad en los puntos organizados en el territorio. 28 JULIO 2021;VACUNA;COVID;VALENCIA;JOVENES Rober Solsona / Europa Press (Foto de ARCHIVO) 28/7/2021

Those people who have been infected with Covid-19 after the complete vaccination schedule must wait 4 weeks after the diagnosis until they receive the booster dose, in case it is their turn, as reported by the Ministry of Health in the tenth update of the document ‘Vaccination strategy against COVID-19 in Spain’.

As recalled in the report, a person with a history of infection is considered to be someone who has a positive test for active infection (PDIA) prior to vaccination or a positive result of IgG by high-performance serology (ELISA or CLIA), independent of the protein detected. Those considered by the Autonomous Communities that are incorporated in the SERLAB registry will also be included as confirmed.

In this sense, it should be remembered that Health recommends the third dose in people over 40 years of age from 6 months if the last dose administered in the primary vaccination was with mRNA vaccine (Pfizer / BioNTech or Moderna), and from 3 months if it was an adenovirus vector vaccine (AstraZeneca or Janssen).

However, the Ministry reiterates that the administration of booster doses in inmates in centers for the elderly and in other social and health centers (including day centers and occupational centers) is considered a priority, regardless of age; people aged 70 and over; people 60-69 years of age; health and social health personnel; and people who received a dose of Janssen vaccine as a primary vaccination and those with the homologous regimen of Astrazeneca.

LEAVE A REPLY

Please enter your comment!
Please enter your name here